N. White

发表

Antiretroviral drug exposure in lymph nodes is heterogeneous and drug dependent

P. Luciw, J. Estes, A. Kashuba, 2022, Journal of the International AIDS Society.

Translational Approach to Predicting the Efficacy of Maraviroc-Based Regimens as HIV Preexposure Prophylaxis

J. Nelson, N. Shaheen, E. Dellon, 2019, Antimicrobial Agents and Chemotherapy.

Heterogeneous antiretroviral drug distribution and HIV/SHIV detection in the gut of three species

P. Luciw, N. Shaheen, E. Dellon, 2019, Science Translational Medicine.

Population Pharmacokinetics of Piperacillin Using Scavenged Samples From Preterm Infants

M. Walsh, N. Newman, D. Ouellet, 2012, Therapeutic drug monitoring.

Population Pharmacokinetics of Metronidazole Evaluated Using Scavenged Samples from Preterm Infants

M. Walsh, N. Newman, P. Smith, 2012, Antimicrobial Agents and Chemotherapy.

Antiretroviral concentrations and surrogate measures of efficacy in the brain tissue and CSF of preclinical species

P. Luciw, J. Garcia, A. Kashuba, 2018, Xenobiotica; the fate of foreign compounds in biological systems.

p16INK4a, a Senescence Marker, Influences Tenofovir/Emtricitabine Metabolite Disposition in HIV‐Infected Subjects

C. Torrice, A. Forrest, C. Sykes, 2016, CPT: pharmacometrics & systems pharmacology.

Mass Spectroscopy Imaging of Hair Strands Captures Short-Term and Long-Term Changes in Emtricitabine Adherence

A. Kashuba, L. Hightow-Weidman, Joseph N. Mwangi, 2022, Antimicrobial agents and chemotherapy.

Population Pharmacokinetics Modeling of Unbound Efavirenz, Atazanavir, and Ritonavir in HIV‐Infected Subjects With Aging Biomarkers

C. Torrice, A. Forrest, C. Sykes, 2016, CPT: pharmacometrics & systems pharmacology.

Tenofovir/Emtricitabine Metabolites and Endogenous Nucleotide Exposures are associated with p16INK4a Expression in Subjects on Combination Therapy

M. Hudgens, N. Sharpless, C. Torrice, 2016, Antiviral therapy.

Predicting Efavirenz Concentrations in the Brain Tissue of HIV‐Infected Individuals and Exploring their Relationship to Neurocognitive Impairment

R. Swanstrom, R. Price, P. Luciw, 2019, Clinical and translational science.

Cervicovaginal and Rectal Fluid as a Surrogate Marker of Antiretroviral Tissue Concentration: Implications for Clinical Trial Design

M. Hudgens, N. Shaheen, E. Dellon, 2016, Journal of acquired immune deficiency syndromes.

Genital Tenofovir Concentrations Correlate With Protection Against HIV Infection in the CAPRISA 004 Trial: Importance of Adherence for Microbicide Effectiveness

S. A. Abdool Karim, T. Gengiah, L. Werner, 2015, Journal of acquired immune deficiency syndromes.

Quantitative Imaging Analysis of the Spatial Relationship between Antiretrovirals, Reverse Transcriptase Simian-Human Immunodeficiency Virus RNA, and Fibrosis in the Spleens of Nonhuman Primates

P. Luciw, K. Busman-Sahay, J. Estes, 2022, Antimicrobial agents and chemotherapy.

Studies on Antiretroviral Drug Concentrations in Breast Milk: Validation of a Liquid Chromatography-Tandem Mass Spectrometric Method for the Determination of 7 Anti-Human Immunodeficiency Virus Medications

S. Moselhy, A. Kashuba, N. Rezk, 2008, Therapeutic drug monitoring.

A Pharmacokinetic/Pharmacodynamic Model to Predict Effective HIV Prophylaxis Dosing Strategies for People Who Inject Drugs

C. Sykes, N. White, Brian M Maas, 2018, The Journal of Pharmacology and Experimental Therapeutics.

Antiretroviral Pharmacokinetics in Mothers and Breastfeeding Infants from 6 to 24 Weeks Post-Partum: Results of the Ban Study

M. Hudgens, F. Martinson, J. Nelson, 2014, Antiviral therapy.

A Translational Pharmacology Approach to Predicting Outcomes of Preexposure Prophylaxis Against HIV in Men and Women Using Tenofovir Disoproxil Fumarate With or Without Emtricitabine.

M. Hudgens, J. Nelson, N. Shaheen, 2016, The Journal of infectious diseases.

Pharmacokinetics of two common antiretroviral regimens in older HIV‐infected patients: a pilot study

A. Forrest, A. Corbett, C. Sykes, 2013, HIV medicine.

Antiretroviral Penetration and Drug Transporter Concentrations in the Spleens of Three Preclinical Animal Models and Humans

Jason R. Pirone, P. Luciw, J. Garcia, 2020, Antimicrobial Agents and Chemotherapy.

Antiretroviral Drug Concentrations in Lymph Nodes: A Cross-Species Comparison of the Effect of Drug Transporter Expression, Viral Infection, and Sex in Humanized Mice, Nonhuman Primates, and Humans

P. Luciw, J. Garcia, A. Kashuba, 2019, The Journal of Pharmacology and Experimental Therapeutics.

Concentrations of Pro-Inflammatory Cytokines Are Not Associated with Senescence Marker p16INK4a or Predictive of Intracellular Emtricitabine/Tenofovir Metabolite and Endogenous Nucleotide Exposures in Adults with HIV Infection

M. Hudgens, N. Sharpless, C. Torrice, 2016, PloS one.

Pharmacokinetics of Tenofovir following Intravaginal and Intrarectal Administration of Tenofovir Gel to Rhesus Macaques

Joseph P. Romano, P. Allen, J. Nuttall, 2011, Antimicrobial Agents and Chemotherapy.

Mass spectrometry imaging of hair identifies daily maraviroc adherence in HPTN 069/ACTG A5305

K. Mayer, R. Gerona, M. Gandhi, 2023, bioRxiv.

Influence of hair treatments on detection of antiretrovirals by mass spectrometry imaging.

A. Kashuba, Joseph N. Mwangi, A. Weideman, 2020, The Analyst.

Antiretroviral Penetration across Three Preclinical Animal Models and Humans in Eight Putative HIV Viral Reservoirs

Jason R. Pirone, P. Luciw, J. Garcia, 2019, Antimicrobial Agents and Chemotherapy.

Effect of HIV Infection and Menopause Status on Raltegravir Pharmacokinetics in the Blood and Genital Tract

A. Kashuba, N. White, K. Patterson, 2015, Antiviral therapy.

An accurate and precise high-performance liquid chromatography method for the rapid quantification of the novel HIV integrase inhibitor raltegravir in human blood plasma after solid phase extraction.

A. Kashuba, N. Rezk, N. White, 2008, Analytica chimica acta.

A novel LC-ESI-MS method for the simultaneous determination of etravirine, darunavir and ritonavir in human blood plasma.

A. Kashuba, N. Rezk, N. White, 2009, Talanta.

Development and validation of an LC-MS/MS assay for the quantification of dolutegravir extracted from human hair

A. Kashuba, B. Tamraz, C. Sykes, 2018, Analytical and Bioanalytical Chemistry.

Title: The Pharmacokinetics of Tenofovir Following Intravaginal and Intrarectal

P. Allen, J. Nuttall, A. Kashuba, 2011 .

Genital Tenofovir Concentrations Correlate With Protection Against HIV Infection in the CAPRISA 004 Trial: Importance of Adherence for Microbicide Effectiveness

S. A. Abdool Karim, T. Gengiah, L. Werner, 2015, Journal of acquired immune deficiency syndromes.